Hoşgeldiniz. Lütfen giriş yapın ya da yeni bir hesap oluşturun

Denosumab versus alendronate: real-world fracture risk

• Univadis Medical News
• salı, 23.nisan 2019

Findings from a cohort of almost 93,000 Danish patients.

Doctor killed in hospital attack

• Univadis Medical News
• salı, 23.nisan 2019

The World Health Organization (WHO) is assessing the security situation.

Trial supports new therapy for resistant rheumatoid arthritis

• Univadis Medical News
• salı, 23.nisan 2019

The new immunoglobulin G1 monoclonal antibody was associated with significant improvements in DAS28-CRP at 12 weeks.

ELCC 2019 - In first-line nonsquamous NSCLC, patients with EGFR mutations benefit from adding atezolizumab to standard care

• Oncology Conference reports
• pazar, 14.nisan 2019

Exploratory subgroup analysis of IMpower150 trial indicates efficacy for EGFR-mt+ patients given atezolizumab in addition to bevacizumab and standard chemotherapy

ELCC 2019 - Is there a role for gut microbiome in clinical responses to lung cancer immunotherapy?

• Oncology Conference reports
• pazar, 14.nisan 2019

Keynote lecture at European Lung Cancer Conference presents arguments for exploring the influence of microbes in precision medicine

ELCC 2019 - Many problems with accessibility to lung cancer care in low and middle income EU countries

• Oncology Conference reports
• pazar, 14.nisan 2019

Most health care systems in the eastern part of the EU are under financed and under equipped to deal with lung cancer